Patents by Inventor Clare RYAN

Clare RYAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIQUID CHROMATOGRAPHY- MASS SPECTROMETRY (LC-MS) METHODS FOR ANALYZING AMPHOLYTE LOT VARIATION
    Publication number: 20240345025
    Abstract: The disclosure relates to methods of characterizing ampholyte compositions suitable for downstream applications such as capillary isoelectric focusing using liquid-chromatography-mass spectrometry.
    Type: Application
    Filed: June 21, 2024
    Publication date: October 17, 2024
    Inventors: Rachel MULLEN, Clare RYAN, Seamus O'CONNOR, Stacey HELMING
  • Liquid chromatography-mass spectrometry (LC-MS) methods for analyzing ampholyte lot variation
    Patent number: 12055518
    Abstract: The disclosure relates to methods of characterizing ampholyte compositions suitable for downstream applications such as capillary isoelectric focusing using liquid-chromatography-mass spectrometry.
    Type: Grant
    Filed: October 9, 2020
    Date of Patent: August 6, 2024
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Rachel Mullen, Clare Ryan, Seamus O'Connor, Stacey Helming
  • IMAGE CAPILLARY ISOELECTRIC FOCUSING TO ANALYZE PROTEIN VARIANTS IN A SAMPLE MATRIX
    Publication number: 20220317088
    Abstract: Embodiments of the present disclosure are directed to methods, systems, devices and kits corresponding to a method for analyzing charge variants of a protein such as vascular endothelial growth factor VEGF-Trap.
    Type: Application
    Filed: June 10, 2022
    Publication date: October 6, 2022
    Inventors: Anu RAMBHADRAN, Peng CUI, Paul BIGWARFE, Michele LASTRO, Clare RYAN, Junyu MA, Kun LU
  • LIQUID CHROMATOGRAPHY- MASS SPECTROMETRY (LC-MS) METHODS FOR ANALYZING AMPHOLYTE LOT VARIATION
    Publication number: 20210109063
    Abstract: The disclosure relates to methods of characterizing ampholyte compositions suitable for downstream applications such as capillary isoelectric focusing using liquid-chromatography-mass spectrometry.
    Type: Application
    Filed: October 9, 2020
    Publication date: April 15, 2021
    Inventors: Rachel MULLEN, Clare RYAN, Seamus O'CONNOR, Stacey HELMING
  • Closure mechanism
    Patent number: 10513876
    Abstract: A closure mechanism is described, the closure mechanism comprising: a base; a carriage movable along the base; a catching mechanism movable along the carriage; a first resilient mechanism connecting the base and the catching mechanism; and a second resilient mechanism connecting the carriage and the catching mechanism.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: December 24, 2019
    Assignee: ASSA ABLOY NEW ZEALAND LIMITED
    Inventors: Bryce Alan Molloy, Brenda Clare Ryan
  • IMAGE CAPILLARY ISOELECTRIC FOCUSING TO ANALYZE PROTEIN VARIANTS IN A SAMPLE MATRIX
    Publication number: 20190056350
    Abstract: Embodiments of the present disclosure are directed to methods, systems, devices and kits corresponding to a method for analyzing charge variants of a protein such as vascular endothelial growth factor VEGF-Trap.
    Type: Application
    Filed: August 17, 2018
    Publication date: February 21, 2019
    Inventors: Anu RAMBHADRAN, Peng CUI, Paul BIGWARFE, Michele LASTRO, Clare RYAN, Junyu MA, Kun LU
  • A CLOSURE MECHANISM
    Publication number: 20180216383
    Abstract: A closure mechanism is described, the closure mechanism comprising: a base; a carriage movable along the base; a catching mechanism movable along the carriage; a first resilient mechanism connecting the base and the catching mechanism; and a second resilient mechanism connecting the carriage and the catching mechanism.
    Type: Application
    Filed: July 29, 2016
    Publication date: August 2, 2018
    Inventors: Bryce Alan MOLLOY, Brenda Clare RYAN
  • Novel oncolytic adenoviral vectors
    Publication number: 20030104625
    Abstract: The present invention relates to oncolytic adenoviral vectors and their use in methods of gene therapy. Provided is a recombinant viral vector comprising an adenoviral nucleic acid backbone, wherein said nucleic acid backbone comprises in sequential order: A left ITR, a termination signal sequence, an E2F responsive promoter which is operably linked to a gene essential for replication of the recombinant viral vector, an adenoviral packaging signal, and a right ITR.
    Type: Application
    Filed: February 22, 2002
    Publication date: June 5, 2003
    Inventors: Cheng Cheng, Lori Clarke, Sheila Connelly, David Leonard Ennist, Suzanne Forry-Schaudies, Mario Gorziglia, Paul L. Hallenbeck, Carl M. Hay, John Leonard Jakubczak, Michael Kaleko, Sandrina Phipps, Seshidhar Reddy Police, Patricia Clare Ryan, David A. Stewart, Yuefeng Xie